The four Atlantic provinces have launched a new initiative to collaborate on clinical trials for medtech and pharmaceutical research, dubbed the Atlantic Clinical Trials Network, or ACTN.
Health authorities from each province, along with industry groups BIOTECanada and Innovative Medicines Canada, have said they will “streamline” the clinical trial process and reduce barriers to patients participating in the trials. They will also offer companies looking to trial products a consolidated bureaucratic infrastructure within which to operate.
“Access to therapeutic clinical trials is part of